临床前常染色体显性阿尔茨海默病的弥散张量MRI结构连接与PET淀粉样蛋白负荷:DIAN队列
本研究基于DIAN前瞻性队列,纳入基线认知正常的30例ADAD突变携带者和38例非携带者,分析DTI结构连接与PIB-PET淀粉样蛋白负荷。结果显示突变携带者额顶控制网络结构连接降低,且与估计发病年限相关,而皮质全局淀粉样负荷与估计发病年限无显著关系。
要点
- ADAD突变携带者额顶控制网络结构连接较非携带者降低。
- 携带者中额顶控制网络结构连接与估计发病年限相关。
- 皮质全局淀粉样负荷与估计发病年限无显著关系。
诊断标准与关键数值
- 结构连接由DTI计算,皮质分为默认模式网络、额顶控制网络和腹侧注意网络三个网络。
- 采用一般线性模型比较携带者与非携带者结构连接差异,并分析结构连接、淀粉样负荷与估计发病年限的关系。
临床应用与阅片要点
- 在临床前ADAD突变携带者中,额顶控制网络结构连接降低可能早于皮质全局淀粉样负荷与估计发病年限的相关性出现。
- 阅片时可关注额顶控制网络白质结构连接的改变,作为ADAD突变携带者早期影像标志物的候选。
局限性
- 探索性分析,样本量较小(30例携带者、38例非携带者)。
- 仅分析基线横断面数据,无法推断结构连接与淀粉样负荷的纵向因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Pathologic evidence of Alzheimer disease (AD) is detectable years before onset of clinical symptoms. Imaging-based identification of structural changes of the brain in people at genetic risk for early-onset AD may provide insights into how genes influence the pathologic cascade that leads to dementia. Purpose To assess structural connectivity differences in cortical networks between cognitively normal autosomal dominant Alzheimer disease (ADAD) mutation carriers versus noncarriers and to determine the cross-sectional relationship of structural connectivity and cortical amyloid burden with estimated years to symptom onset (EYO) of dementia in carriers. Materials and Methods In this exploratory analysis of a prospective trial, all participants enrolled in the Dominantly Inherited Alzheimer Network between January 2009 and July 2014 who had normal cognition at baseline, T1-weighted MRI scans, and diffusion tensor imaging (DTI) were analyzed. Amyloid PET imaging using Pittsburgh compound B was also analyzed for mutation carriers. Areas of the cerebral cortex were parcellated into three cortical networks: the default mode network, frontoparietal control network, and ventral attention network. The structural connectivity of the three networks was calculated from DTI. General linear models were used to examine differences in structural connectivity between mutation carriers and noncarriers and the relationship between structural connectivity, amyloid burden, and EYO in mutation carriers. Correlation network analysis was performed to identify clusters of related clinical and imaging markers. Results There were 30 mutation carriers (mean age ± standard deviation, 34 years ± 10; 17 women) and 38 noncarriers (mean age, 37 years ± 10; 20 women). There was lower structural connectivity in the frontoparietal control network in mutation carriers compared with noncarriers (estimated effect of mutation-positive status, -0.0266; P = .04). Among mutation carriers, there was a correlation between EYO and white matter structural connectivity in the frontoparietal control network (estimated effect of EYO, -0.0015, P = .01). There was no significant relationship between cortical global amyloid burden and EYO among mutation carriers (P > .05). Conclusion White matter structural connectivity was lower in autosomal dominant Alzheimer disease mutation carriers compared with noncarriers and correlated with estimated years to symptom onset. Clinical trial registration no. NCT00869817 © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by McEvoy in this issue.
引用
- Prescott JW, Doraiswamy PM, Gamberger D, et al. Diffusion Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort. Radiology. 2021. PMID: 34636637. doi:10.1148/radiol.2021210383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。